Drugs

Health Canada approves 2nd generic version of Ozempic—and it's Canadian
Canada is the first of the G-7 countries to authorize generic semaglutide.
What to know about psychedelic retreats, a booming business with few safety guardrails
Surging interest in the purported benefits of psychedelic drugs has given rise to books, documentaries and conferences dedicated to the mind-altering substances. Now add one more business to the list: psychedelic retreats.

Do certain pharmacotherapies for IBS increase the risk of mortality?

Study examines the risk of all-cause mortality with approved and off-label pharmacotherapies for irritable bowel syndrome (IBS).
Health Canada approves first generic version of Ozempic in the country

The federal agency says it continues to review eight other generic semaglutide submissions from other companies.
How to avoid dosing interval errors

Since most medications are taken daily, doses outside that interval have a lot of error potential.
Topical Steroid Withdrawal: distinct condition or diagnostic grey zone?

While some view it as a social-media-driven phenomenon, TSW is typically reported after prolonged use of moderate to high-intensity topical corticosteroids for eczema.
POP QUIZ: Bempedoic acid (nilemdo) for lipid lowering

Which statement about the new lipid-lowering agent Nilemdo (bempedoic acid) is FALSE?
B.C. college hosting final CIRCL webinar before June 1 deadline

Session will help pharmacies prepare for full rollout of mandatory medication incident reporting rules. Check out some of the previous sessions right here.
Drug development accelerator opens at University of Toronto

Canadian branch of BioLabs, an international health sciences research and development innovation infrastructure company is located in the MaRS Discovery District.
Five osteoporosis pearls: Clinical tips for treating men and women

‘The promise of a drug holiday may actually inspire patients to take their bisphosphonate.’

Health Canada approves 2nd generic version of Ozempic—and it's Canadian

What to know about psychedelic retreats, a booming business with few safety guardrails

Do certain pharmacotherapies for IBS increase the risk of mortality?

Health Canada approves first generic version of Ozempic in the country

How to avoid dosing interval errors

Topical Steroid Withdrawal: distinct condition or diagnostic grey zone?

POP QUIZ: Bempedoic acid (nilemdo) for lipid lowering

B.C. college hosting final CIRCL webinar before June 1 deadline

Drug development accelerator opens at University of Toronto

Five osteoporosis pearls: Clinical tips for treating men and women